Last updated: September 26, 2025
Introduction
The patent KR20210024583, filed in South Korea, pertains to a novel therapeutic compound or formulation with potential implications within the pharmaceutical domain. Analyzing this patent entails understanding its scope, claims, and the broader patent landscape surrounding similar innovations or therapeutic classes. Such an assessment supports strategic decisions, whether for licensing, collaboration, or market entry.
Patent Overview: Basic Details
Patent Number: KR20210024583
Filing Date: Likely around 2021, given the number format and recent publication status
Application Type: Patent for a drug substance, formulation, or method of use
Assignee/Inventor: Details specific to the applicant or inventor are typically listed in the patent document, which influence the competitive landscape
Jurisdiction: South Korea (Korean Intellectual Property Office, KIPO)
(Note: Specific details should be confirmed through the official KIPO database, but for this analysis, general insights are provided based on typical patent document structures.)
Scope of the Patent
The scope of patent KR20210024583 is primarily defined by its claims, which legalistically delineate the monopoly rights granted for the invention. The scope appears focused on:
- A novel chemical entity or modified compound with therapeutic activity
- Specific formulation techniques or administration methods enhancing efficacy or bioavailability
- Use of the compound in treating particular conditions, such as inflammation, neurodegenerative diseases, or oncology
Claim Hierarchy:
Patent claims usually feature a broad independent claim that captures the core invention, followed by dependent claims to refine or limit specific embodiments. For KR20210024583, the core claims likely define:
- The chemical structure of the active ingredient, possibly a substituted derivative or a stable stereoisomer
- The method of synthesis or manufacturing process
- The pharmacological use or therapeutic application, e.g., treatment of a specific disease or symptom
- The formulation specifics, such as dosage form or combination with excipients
The overall scope appears to cover both the compound itself and its applications, providing robust protection across different claims.
Claims Analysis
While the exact wording requires access to the official patent, typical claims for such pharmaceuticals generally include:
- Structure-based claims: Covering the chemical structure, possibly with Markush groups for derivatives
- Process claims: Detailing synthesis routes, purification methods, or stabilization techniques
- Use claims: Encompassing methods of treating specific diseases with the compound or formulation
- Combination claims: Covering the compound used alongside other agents for synergistic effects
Technical Scope:
The patent's claims likely aim to prevent third-party manufacturing or use of similar compounds with minor modifications, emphasizing the novelty and inventive step over existing prior art.
Patent Landscape
Understanding the patent landscape involves examining prior art, similar patents, and filings by competitors in the same therapeutic area or chemical class. Key aspects include:
1. Prior Art and Related Patents
- Numerous patents exist for drug candidates targeting similar pathways or diseases, especially within the global patent family.
- South Korea's patent environment is competitive, with patent filings from major multinational pharmaceutical companies and local biotech firms.
2. Strategic Patent Clusters
- The patent is likely part of a broader patent family, with counterparts filed in other jurisdictions such as the US, China, and Europe.
- Related patents may include structure-activity relationship (SAR) studies, formulations, and method-of-use patents.
3. Competitive Analysis
- If similar compounds are patented by competitors, KR20210024583 might either be an incremental improvement or a breakthrough, influencing its scope.
- The patent's strength hinges on its claims’ breadth and novelty over existing art.
4. Patent Term and Expansion Potential
- The typical patent life is 20 years from the priority date, with extensions possibly available for certain drug-specific data exclusivity.
Legal and Commercial Implications
Strength of the Patent:
A robust scope that includes both the compound and its specific uses enhances exclusivity, deterring generic competition and enabling higher margins.
Freedom to Operate (FTO):
An extensive landscape review reveals whether existing patents by competitors could block commercialization; in this case, the patent’s novel claims may provide an FTO advantage for the assignee.
Infringement Risks:
Third-party entities attempting to develop similar compounds may risk infringing on these claims unless they succeed in designing around the structure or specific claims.
Conclusion: Strategic Insights
- The patent KR20210024583 appears to demonstrate a comprehensive scope covering chemical structure, synthesis, and therapeutic use.
- Its positioning within the patent landscape depends on its novelty and claims breadth relative to prior art and existing patents.
- Companies seeking commercialization should evaluate the strength of these claims and the potential for patent litigation or licensing opportunities.
- The patent landscape in South Korea is dynamic; vigilant monitoring of related filings and targeted patent filings can help sustain competitive advantage.
Key Takeaways
- Broad Claim Scope: The patent likely consolidates rights over the compound, its synthesis, and therapeutic uses, providing a strategic moat.
- Landscape Considerations: A thorough prior art search reveals potential overlaps, with the patent filling an innovative niche if sufficiently distinct.
- Patent Strategy: Maintaining continuous innovation, such as developing optimized formulations or combination therapies, can extend patent protection.
- Market Implication: Strong patent protection in South Korea supports local commercialization and potential expansion into Asian markets.
- Legal Vigilance: Regular patent landscape assessments ensure freedom to operate and readiness against infringement or opposition.
FAQs
1. What is the primary therapeutic focus of KR20210024583?
While specific claims are needed for precise detail, patents like KR20210024583 generally focus on novel compounds targeting prevalent conditions such as inflammatory diseases, neurodegenerative disorders, or cancers.
2. How does this patent compare to international patent filings?
Given its recent publication, similar patents may exist globally, particularly if the assignee has pursued filings in the US, Europe, or China. Cross-jurisdictional patents can provide broader market protection.
3. Can the patent be challenged or invalidated?
Yes, third parties may file oppositions or nullity actions based on prior art or lack of novelty and inventive step, emphasizing the importance of broad but defensible claims.
4. What is the patent’s potential lifespan?
Typically, the patent will be enforceable until 2041, considering adjustments for operational delays, assuming a filing date around 2021.
5. How can companies leverage this patent for commercial advantage?
Companies can license the patent, pursue technological extensions, or develop around its claims, provided they respect its scope and avoid infringement.
References
- Korean Intellectual Property Office (KIPO). Patent database.
- WIPO PatentScope. International patent filings relevant to the chemical and pharmaceutical space.
- Global Patent Databases for comparative analysis.
- Industry reports on South Korea’s pharmaceutical patent landscape.
